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Preface 
Special issue on “Formulation strategies and 
manufacturing technologies to enhance 
non-invasive drug delivery”
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Oral dosage forms including tablets and capsules are the
most commonly used drug products. For some poorly water-
soluble and poorly permeable drugs injectable dosage forms
can be used to circumvent the challenges of poor bioavailabil-
ity. However, injectable dosage forms are not always preferred
and may in the worst case exert limitations on patient com-
pliance for example needle pain, needle fear, or needle stick
injuries. Furthermore, they often require health care profes-
sionals for the administration. Development of non-invasive
drug delivery systems such as pulmonary, ocular, and trans-
dermal delivery have been an intensive research area in the
field of pharmaceutical sciences, which can exert both topical
and systemic pharmacological effects. In addition, novel for-
mulation technologies are continuously evolved to enhance
the oral bioavailability of drugs with poor physicochemical
properties. 
The contributions in this special issue reflect the wide in-
terest in enhancing non-invasive drug delivery by using var-
ious formulation strategies and manufacturing technologies.
The special issue consists of one review and nine research ar-
ticles. It starts with a review article focusing on the research
and development of alternative delivery strategies for apo-
morphine, aiming to highlight the potential of non-invasive
apomorphine delivery for the treatment of Parkinson’s dis-
ease for instance via the sublingual and transdermal admin-
istration routes [1] . The first two research papers in the spe-
cial issue focus on transdermal delivery and ocular delivery,
respectively. Lu et al. used nanocrystal technology to improve
transdermal delivery of meloxicam, where the preparation, in
vitro and in vivo evaluation of the formulations were reported
[2] . To improve the corneal permeability of the poorly water-
soluble drug, disulfiram, for the treatment of cataract, Jiang
et al. formulated the drug into a thermosensitive in-situ gel
based on a solid dispersion [3] . The subsequent three research
articles in the special issue report on the feasibility of a self-
nanoemulsifiying drug delivery system [4] , amorphous solidPeer review under responsibility of Shenyang Pharmaceutical Unive
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bioavailability of a lipophilic drug, a hydrophobic drug, and a
polar drug, respectively. Continuing with oral dosage forms,
the sixth research paper showcases a matrix tablet formula-
tion strategy for sustained-release of a highly water-soluble
drug [7] . The seventh and eighth research papers report on the
transfer of formulation strategies into manufacturing. Bohr et
al. reported critical effects of solvent composition on the qual-
ity attributes of electrosprayed polymeric microparticles [8] ,
and the study by Rantanen et al. demonstrated that 3D print-
ing could be used for prototyping of both parts of production
line and PAT interfacing solution [9] . In the last research pa-
per of this special issue, Rosenholm et al. present that surface-
modified mesoporous silica nanoparticles could be considered
as prospective vectors for therapeutic siRNA delivery [10] . 
The guest editors wish to take this opportunity to thank
the reviewers for their valuable comments and constructive
suggestions. We are also grateful to all the authors for the ex-
cellent contributions and great support, making this special
issue possible. We hope this special issue will be of interest to
many readers. 
Korbinian Löbmann
Adam Bohr
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